APO Research
Talk to an analyst

APO RESEARCH · REPORT

NSAIDs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global NSAIDs Industry Growth and Trends Forecast to 2032

26 December 2025105 pages

Choose your research edition.

Industry ResearchNSAIDs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal NSAIDs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NSAIDs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal NSAIDs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global NSAIDs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NSAIDs include Cigna, Geri-Care Pharmaceuticals, GlaxoSmithKline, Kopran, Novacap, Perrigo Company, Reddy Pharmaceuticals, Sun Pharmaceutical Industries and Verywell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global NSAIDs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The NSAIDs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NSAIDs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NSAIDs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global NSAIDs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

NSAIDs Market by Company

Cigna

Geri-Care Pharmaceuticals

GlaxoSmithKline

Kopran

Novacap

Perrigo Company

Reddy Pharmaceuticals

Sun Pharmaceutical Industries

Verywell

Bayer

Pfizer

Merck Sharp & Dohme

Johnson & Johnson

Abbott

NSAIDs Segment by Type

Naproxen

Nabumetone

Ibuprofen

Aspirin

Others

NSAIDs Segment by Application

Back Pain Treatment

Osteoarthritis Treatment

Other Disease Treatment

NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Naproxen Table 2. Major Company of Nabumetone Table 3. Major Company of Ibuprofen Table 4. Major Company of Aspirin Table 5. Major Company of Others Table 6. Global NSAIDs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global NSAIDs Sales by Type (2021-2026) & (K Units) Table 8. Global NSAIDs Sales Market Share in Volume by Type (2021-2026) Table 9. Global NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 10. Global NSAIDs Sales Market Share in Value by Type (2021-2026) Table 11. Global NSAIDs Price by Type (2021-2026) & (US$/Unit) Table 12. Global NSAIDs Sales by Type (2027-2032) & (K Units) Table 13. Global NSAIDs Sales Market Share in Volume by Type (2027-2032) Table 14. Global NSAIDs Sales by Type (2027-2032) & (US$ Million) Table 15. Global NSAIDs Sales Market Share in Value by Type (2027-2032) Table 16. Global NSAIDs Price by Type (2027-2032) & (US$/Unit) Table 17. North America NSAIDs Sales by Type (2021-2026) & (K Units) Table 18. North America NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe NSAIDs Sales by Type (2021-2026) & (K Units) Table 20. Europe NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific NSAIDs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America NSAIDs Sales by Type (2021-2026) & (K Units) Table 24. Latin America NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa NSAIDs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 27. NSAIDs Industry Trends Table 28. NSAIDs Industry Drivers Table 29. NSAIDs Industry Opportunities and Challenges Table 30. NSAIDs Industry Restraints Table 31. Global NSAIDs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global NSAIDs Revenue Market Share by Company (2021-2026) Table 33. Global NSAIDs Sales by Company (2021-2026) & (K Units) Table 34. Global NSAIDs Sales Share by Company (2021-2026) Table 35. Global NSAIDs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global NSAIDs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global NSAIDs Major Company Production Sites and Headquarters Table 38. Global NSAIDs Company, Product Type & Application Table 39. Global NSAIDs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global NSAIDs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global NSAIDs Sales by Region (2021-2026) & (K Units) Table 44. Global NSAIDs Sales Market Share in Volume by Region (2021-2026) Table 45. Global NSAIDs Sales by Region (2021-2026) & (US$ Million) Table 46. Global NSAIDs Sales Market Share in Value by Region (2021-2026) Table 47. Global NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global NSAIDs Sales by Region (2027-2032) & (K Units) Table 49. Global NSAIDs Sales Market Share in Volume by Region (2027-2032) Table 50. Global NSAIDs Sales by Region (2027-2032) & (US$ Million) Table 51. Global NSAIDs Sales Market Share in Value by Region (2027-2032) Table 52. Global NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global NSAIDs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global NSAIDs Sales by Application (2021-2026) & (K Units) Table 55. Global NSAIDs Sales Market Share in Volume by Application (2021-2026) Table 56. Global NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 57. Global NSAIDs Sales Market Share in Value by Application (2021-2026) Table 58. Global NSAIDs Price by Application (2021-2026) & (US$/Unit) Table 59. Global NSAIDs Sales by Application (2027-2032) & (K Units) Table 60. Global NSAIDs Sales Market Share in Volume by Application (2027-2032) Table 61. Global NSAIDs Sales by Application (2027-2032) & (US$ Million) Table 62. Global NSAIDs Sales Market Share in Value by Application (2027-2032) Table 63. Global NSAIDs Price by Application (2027-2032) & (US$/Unit) Table 64. North America NSAIDs Sales by Application (2021-2026) & (K Units) Table 65. North America NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe NSAIDs Sales by Application (2021-2026) & (K Units) Table 67. Europe NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific NSAIDs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America NSAIDs Sales by Application (2021-2026) & (K Units) Table 71. Latin America NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa NSAIDs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 74. Cigna Company Information Table 75. Cigna Business Overview Table 76. Cigna NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Cigna NSAIDs Product Portfolio Table 78. Cigna Recent Development Table 79. Geri-Care Pharmaceuticals Company Information Table 80. Geri-Care Pharmaceuticals Business Overview Table 81. Geri-Care Pharmaceuticals NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Geri-Care Pharmaceuticals NSAIDs Product Portfolio Table 83. Geri-Care Pharmaceuticals Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline NSAIDs Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Kopran Company Information Table 90. Kopran Business Overview Table 91. Kopran NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Kopran NSAIDs Product Portfolio Table 93. Kopran Recent Development Table 94. Novacap Company Information Table 95. Novacap Business Overview Table 96. Novacap NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novacap NSAIDs Product Portfolio Table 98. Novacap Recent Development Table 99. Perrigo Company Company Information Table 100. Perrigo Company Business Overview Table 101. Perrigo Company NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Perrigo Company NSAIDs Product Portfolio Table 103. Perrigo Company Recent Development Table 104. Reddy Pharmaceuticals Company Information Table 105. Reddy Pharmaceuticals Business Overview Table 106. Reddy Pharmaceuticals NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Reddy Pharmaceuticals NSAIDs Product Portfolio Table 108. Reddy Pharmaceuticals Recent Development Table 109. Sun Pharmaceutical Industries Company Information Table 110. Sun Pharmaceutical Industries Business Overview Table 111. Sun Pharmaceutical Industries NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sun Pharmaceutical Industries NSAIDs Product Portfolio Table 113. Sun Pharmaceutical Industries Recent Development Table 114. Verywell Company Information Table 115. Verywell Business Overview Table 116. Verywell NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Verywell NSAIDs Product Portfolio Table 118. Verywell Recent Development Table 119. Bayer Company Information Table 120. Bayer Business Overview Table 121. Bayer NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Bayer NSAIDs Product Portfolio Table 123. Bayer Recent Development Table 124. Pfizer Company Information Table 125. Pfizer Business Overview Table 126. Pfizer NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Pfizer NSAIDs Product Portfolio Table 128. Pfizer Recent Development Table 129. Merck Sharp & Dohme Company Information Table 130. Merck Sharp & Dohme Business Overview Table 131. Merck Sharp & Dohme NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Merck Sharp & Dohme NSAIDs Product Portfolio Table 133. Merck Sharp & Dohme Recent Development Table 134. Johnson & Johnson Company Information Table 135. Johnson & Johnson Business Overview Table 136. Johnson & Johnson NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Johnson & Johnson NSAIDs Product Portfolio Table 138. Johnson & Johnson Recent Development Table 139. Abbott Company Information Table 140. Abbott Business Overview Table 141. Abbott NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Abbott NSAIDs Product Portfolio Table 143. Abbott Recent Development Table 144. North America NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. North America NSAIDs Sales by Country (2021-2026) & (K Units) Table 146. North America NSAIDs Sales Market Share by Country (2021-2026) Table 147. North America NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 148. North America NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 149. North America NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 151. North America NSAIDs Market Share by Country (2021-2026) Table 152. North America NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America NSAIDs Market Share Forecast by Country (2027-2032) Table 154. Europe NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Europe NSAIDs Sales by Country (2021-2026) & (K Units) Table 156. Europe NSAIDs Sales Market Share by Country (2021-2026) Table 157. Europe NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 158. Europe NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 159. Europe NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe NSAIDs Market Share by Country (2021-2026) Table 162. Europe NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe NSAIDs Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific NSAIDs Sales by Country (2021-2026) & (K Units) Table 166. Asia-Pacific NSAIDs Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 168. Asia-Pacific NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific NSAIDs Market Share by Country (2021-2026) Table 172. Asia-Pacific NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific NSAIDs Market Share Forecast by Country (2027-2032) Table 174. Latin America NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Latin America NSAIDs Sales by Country (2021-2026) & (K Units) Table 176. Latin America NSAIDs Sales Market Share by Country (2021-2026) Table 177. Latin America NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 178. Latin America NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America NSAIDs Market Share by Country (2021-2026) Table 182. Latin America NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America NSAIDs Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa NSAIDs Sales by Country (2021-2026) & (K Units) Table 186. Middle East and Africa NSAIDs Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 188. Middle East and Africa NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa NSAIDs Market Share by Country (2021-2026) Table 192. Middle East and Africa NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa NSAIDs Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. NSAIDs Distributors List Table 197. NSAIDs Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. NSAIDs Image Figure 2. Global NSAIDs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NSAIDs Market Size (2021-2032) & (US$ Million) Figure 4. Global NSAIDs Sales (2021-2032) & (K Units) Figure 5. Naproxen Image Figure 6. Global Naproxen Sales YoY Growth (2021-2032) & (K Units) Figure 7. Nabumetone Image Figure 8. Global Nabumetone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Ibuprofen Image Figure 10. Global Ibuprofen Sales YoY Growth (2021-2032) & (K Units) Figure 11. Aspirin Image Figure 12. Global Aspirin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global NSAIDs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global NSAIDs Market Share by Type 2025 VS 2032 Figure 17. North America NSAIDs Sales Market Share in Volume by Type in 2025 Figure 18. North America NSAIDs Sales Market Share in Value by Type in 2025 Figure 19. Europe NSAIDs Sales Market Share in Volume by Type in 2025 Figure 20. Europe NSAIDs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific NSAIDs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific NSAIDs Sales Market Share in Value by Type in 2025 Figure 23. Latin America NSAIDs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America NSAIDs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa NSAIDs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa NSAIDs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 NSAIDs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Back Pain Treatment Image Figure 30. Global Back Pain Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 31. Osteoarthritis Treatment Image Figure 32. Global Osteoarthritis Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Disease Treatment Image Figure 34. Global Other Disease Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global NSAIDs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global NSAIDs Market Share by Application 2025 VS 2032 Figure 37. North America NSAIDs Sales Market Share in Volume by Application in 2025 Figure 38. North America NSAIDs Sales Market Share in Value by Application in 2025 Figure 39. Europe NSAIDs Sales Market Share in Volume by Application in 2025 Figure 40. Europe NSAIDs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific NSAIDs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific NSAIDs Sales Market Share in Value by Application in 2025 Figure 43. Latin America NSAIDs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America NSAIDs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa NSAIDs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa NSAIDs Sales Market Share in Value by Application in 2025 Figure 47. North America NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. NSAIDs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. NSAIDs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Nabumetone
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • Back Pain Treatment
  • Osteoarthritis Treatment
  • Other Disease Treatment
Companies covered
  • Cigna
  • Geri-Care Pharmaceuticals
  • GlaxoSmithKline
  • Kopran
  • Novacap
  • Perrigo Company
  • Reddy Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Verywell
  • Bayer
  • Pfizer
  • Merck Sharp & Dohme
  • Johnson & Johnson
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NSAIDs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global NSAIDs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 NSAIDs Market by Type
  6. 1.3.1 Naproxen
  7. 1.3.2 Nabumetone
  8. 1.3.3 Ibuprofen
  9. 1.3.4 Aspirin
  10. 1.3.5 Others
  11. 1.4 Global NSAIDs Market Size by Type
  12. 1.4.1 Global NSAIDs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global NSAIDs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global NSAIDs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America NSAIDs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe NSAIDs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific NSAIDs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America NSAIDs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa NSAIDs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 NSAIDs Industry Trends
  2. 2.2 NSAIDs Industry Drivers
  3. 2.3 NSAIDs Industry Opportunities and Challenges
  4. 2.4 NSAIDs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by NSAIDs Revenue (2021-2026)
  2. 3.2 Global Top Players by NSAIDs Sales (2021-2026)
  3. 3.3 Global Top Players by NSAIDs Price (2021-2026)
  4. 3.4 Global NSAIDs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NSAIDs Major Company Production Sites & Headquarters
  6. 3.6 Global NSAIDs Company, Product Type & Application
  7. 3.7 Global NSAIDs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NSAIDs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NSAIDs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NSAIDs Tier 1, Tier 2, and Tier 3
4 NSAIDs Regional Status and Outlook
  1. 4.1 Global NSAIDs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global NSAIDs Historic Market Size by Region
  3. 4.2.1 Global NSAIDs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global NSAIDs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global NSAIDs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global NSAIDs Forecasted Market Size by Region
  7. 4.3.1 Global NSAIDs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global NSAIDs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global NSAIDs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NSAIDs by Application
  1. 5.1 NSAIDs Market by Application
  2. 5.1.1 Back Pain Treatment
  3. 5.1.2 Osteoarthritis Treatment
  4. 5.1.3 Other Disease Treatment
  5. 5.2 Global NSAIDs Market Size by Application
  6. 5.2.1 Global NSAIDs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global NSAIDs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global NSAIDs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America NSAIDs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe NSAIDs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific NSAIDs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America NSAIDs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa NSAIDs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cigna
  2. 6.1.1 Cigna Company Information
  3. 6.1.2 Cigna Business Overview
  4. 6.1.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cigna NSAIDs Product Portfolio
  6. 6.1.5 Cigna Recent Developments
  7. 6.2 Geri-Care Pharmaceuticals
  8. 6.2.1 Geri-Care Pharmaceuticals Company Information
  9. 6.2.2 Geri-Care Pharmaceuticals Business Overview
  10. 6.2.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio
  12. 6.2.5 Geri-Care Pharmaceuticals Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline NSAIDs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Kopran
  20. 6.4.1 Kopran Company Information
  21. 6.4.2 Kopran Business Overview
  22. 6.4.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kopran NSAIDs Product Portfolio
  24. 6.4.5 Kopran Recent Developments
  25. 6.5 Novacap
  26. 6.5.1 Novacap Company Information
  27. 6.5.2 Novacap Business Overview
  28. 6.5.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novacap NSAIDs Product Portfolio
  30. 6.5.5 Novacap Recent Developments
  31. 6.6 Perrigo Company
  32. 6.6.1 Perrigo Company Company Information
  33. 6.6.2 Perrigo Company Business Overview
  34. 6.6.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Perrigo Company NSAIDs Product Portfolio
  36. 6.6.5 Perrigo Company Recent Developments
  37. 6.7 Reddy Pharmaceuticals
  38. 6.7.1 Reddy Pharmaceuticals Company Information
  39. 6.7.2 Reddy Pharmaceuticals Business Overview
  40. 6.7.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Reddy Pharmaceuticals NSAIDs Product Portfolio
  42. 6.7.5 Reddy Pharmaceuticals Recent Developments
  43. 6.8 Sun Pharmaceutical Industries
  44. 6.8.1 Sun Pharmaceutical Industries Company Information
  45. 6.8.2 Sun Pharmaceutical Industries Business Overview
  46. 6.8.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Industries Recent Developments
  49. 6.9 Verywell
  50. 6.9.1 Verywell Company Information
  51. 6.9.2 Verywell Business Overview
  52. 6.9.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Verywell NSAIDs Product Portfolio
  54. 6.9.5 Verywell Recent Developments
  55. 6.10 Bayer
  56. 6.10.1 Bayer Company Information
  57. 6.10.2 Bayer Business Overview
  58. 6.10.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bayer NSAIDs Product Portfolio
  60. 6.10.5 Bayer Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer NSAIDs Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Merck Sharp & Dohme
  68. 6.12.1 Merck Sharp & Dohme Company Information
  69. 6.12.2 Merck Sharp & Dohme Business Overview
  70. 6.12.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Sharp & Dohme NSAIDs Product Portfolio
  72. 6.12.5 Merck Sharp & Dohme Recent Developments
  73. 6.13 Johnson & Johnson
  74. 6.13.1 Johnson & Johnson Company Information
  75. 6.13.2 Johnson & Johnson Business Overview
  76. 6.13.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Johnson & Johnson NSAIDs Product Portfolio
  78. 6.13.5 Johnson & Johnson Recent Developments
  79. 6.14 Abbott
  80. 6.14.1 Abbott Company Information
  81. 6.14.2 Abbott Business Overview
  82. 6.14.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abbott NSAIDs Product Portfolio
  84. 6.14.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America NSAIDs Sales by Country
  2. 7.1.1 North America NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America NSAIDs Sales by Country (2021-2026)
  4. 7.1.3 North America NSAIDs Sales Forecast by Country (2027-2032)
  5. 7.2 North America NSAIDs Market Size by Country
  6. 7.2.1 North America NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America NSAIDs Market Size by Country (2021-2026)
  8. 7.2.3 North America NSAIDs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe NSAIDs Sales by Country
  2. 8.1.1 Europe NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe NSAIDs Sales by Country (2021-2026)
  4. 8.1.3 Europe NSAIDs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe NSAIDs Market Size by Country
  6. 8.2.1 Europe NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe NSAIDs Market Size by Country (2021-2026)
  8. 8.2.3 Europe NSAIDs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific NSAIDs Sales by Country
  2. 9.1.1 Asia-Pacific NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific NSAIDs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific NSAIDs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific NSAIDs Market Size by Country
  6. 9.2.1 Asia-Pacific NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific NSAIDs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific NSAIDs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America NSAIDs Sales by Country
  2. 10.1.1 South America NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America NSAIDs Sales by Country (2021-2026)
  4. 10.1.3 South America NSAIDs Sales Forecast by Country (2027-2032)
  5. 10.2 South America NSAIDs Market Size by Country
  6. 10.2.1 South America NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America NSAIDs Market Size by Country (2021-2026)
  8. 10.2.3 South America NSAIDs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa NSAIDs Sales by Country
  2. 11.1.1 Middle East and Africa NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa NSAIDs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa NSAIDs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa NSAIDs Market Size by Country
  6. 11.2.1 Middle East and Africa NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa NSAIDs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa NSAIDs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 NSAIDs Value Chain Analysis
  2. 12.1.1 NSAIDs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 NSAIDs Production Mode & Process
  7. 12.2 NSAIDs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 NSAIDs Distributors
  10. 12.2.3 NSAIDs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst